Evidence map›Paper›PMID 24586629›Full record

ArticlePloS one2014

Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin.

Michal Mlacki, Charbel Darido, Stephen M Jane, Tomasz Wilanowski

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Meta-Analysis ofGenes · 2019
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Vitamin D Receptor Regulates the Expression of the Grainyhead-Like 1 Gene.International journal of molecular sciences · 2024
    Article
  7. Exploration of the Correlation BetweenPharmacogenomics and personalized medicine · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Grainyhead-like (Grhl) Target Genes in Development and Cancer.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Desmosomes as Signaling Hubs in the Regulation of Cell Behavior.Frontiers in cell and developmental biology · 2021
    Review
  20. Grainyhead-like transcription factors in cancer - Focus on recent developments.Experimental biology and medicine (Maywood, N.J.) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Michal MlackiLaboratory of Signal Transduction, Nencki Institute of Experimental Biology, Warsaw, Poland.
Charbel DaridoDepartment of Medicine, Monash University Central Clinical School, Prahran, Victoria, Australia.
Stephen M JaneDepartment of Medicine, Monash University Central Clinical School, Prahran, Victoria, Australia ; Alfred Hospital, Prahran, Victoria, Australia.
Tomasz WilanowskiLaboratory of Signal Transduction, Nencki Institute of Experimental Biology, Warsaw, Poland.
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLMonash University · AUThe Alfred Hospital · AU

Funding

Worldwide Cancer Research 11-0060
6 · The paper itself

Abstract

The Grainyhead-like 1 (GRHL1) transcription factor regulates the expression of desmosomal cadherin desmoglein 1 (Dsg1) in suprabasal layers of the epidermis. As a consequence, the epidermis of Grhl1-null mice displays fewer desmosomes that are abnormal in structure. These mice also exhibit mild chronic skin barrier defects as evidenced by altered keratinocyte terminal differentiation, increased expression of inflammatory markers and infiltration of the skin by immune cells. Exposure of Grhl1 (-/-) mice to a standard chemical skin carcinogenesis protocol results in development of fewer papillomas than in wild type control animals, but with a rate of conversion to squamous cell carcinoma (SCC) that is strikingly higher than in normal littermates. The underlying molecular mechanism differs from mice with conditional ablation of a closely related Grhl family member, Grhl3, in the skin, which develop SCC due to the loss of expression of phosphatase and tensin homolog (PTEN) and activation of the phosphatidylinositol 3-kinase (PI3K)/AKT/mechanistic target of rapamycin (mTOR) signaling pathway.

Indexed as

Cell Membrane Permeability9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogensCarcinoma, Squamous CellCell DifferentiationCell ProliferationEpidermisFluorescent Antibody TechniqueImmunoenzyme TechniquesMast CellsMiceMice, KnockoutPapillomaReal-Time Polymerase Chain ReactionRepressor Proteins9,10-Dimethyl-1,2-benzanthraceneCarcinogensGrhl1 protein, mouseRepressor ProteinsRNA, Messenger

Identifiers

PMID24586629
PMCPMC3930704
OpenAlexW2081470147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.